share_log

Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9

Rodman & Renshaw Initiates Coverage On Omeros With Buy Rating, Announces Price Target of $9

羅德曼&倫肖開始覆蓋奧麥羅製藥,並給予買入評級,宣佈目標股價爲9美元
Benzinga ·  11/14 06:53  · 評級/大行評級

Rodman & Renshaw analyst Brandon Folkes initiates coverage on Omeros (NASDAQ:OMER) with a Buy rating and announces Price Target of $9.

羅德曼和倫肖分析師布蘭登·福爾克斯開始對Omeros(納斯達克股票代碼:OMER)進行報道,評級爲買入,並宣佈目標股價爲9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論